Trade
Sotac Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹129.85(0.00%)July 8, 2025 09:07:41 AM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 10.02 K
Sotac Pharmaceuticals is trading -% upper at Rs 129.85 as compared to its last closing price. Listed peers of Sotac Pharmaceuticals include Nirman Agri Gentics (3.23%), Arham Technologies (-%), Sotac Pharmaceuticals (-%).The Mutual Fund holding in Sotac Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sotac Pharmaceuticals was at 15.12% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 09, 2025, 03:56 AM UTC
- Dividend YieldLower than industry0.07Annual dividends as a percentage of the stock price.
- P/BIn line with historical values2.83The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values18.82Price-to-earnings ratio based on trailing 12-month earnings
- Debt To EquityHigher than industry0.82The debt-to-equity ratio, indicating a company's financial leverage.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Sotac Pharmaceuticals News
Sotac Pharmaceuticals Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Financial insights for Sotac Pharmaceuticals are currently unavailable
Please check back later.
Sotac Pharmaceuticals Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 155.02
- R2
- 164.93
- R3
- 177.52
Pivot142.43
- S1
- 132.52
- S2
- 119.93
- S3
- 110.02
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Sotac Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Nirman Agri Gentics | Bearish | 189.95 | 3.23 | 152.14 | 6.09 | 1.4 | - | - |
| Arham Technologies | Bearish | 86.55 | - | 146.44 | 20.97 | 4.89 | - | 4.92 |
| Sotac Pharmaceuticals | Bullish | 129.85 | - | 143.48 | 18.82 | 2.83 | - | 26.65 |
| Lakshya Powertech | Bearish | 138.85 | - | 140.02 | 7.87 | 1.54 | - | - |
| Sheetal Universal | Bullish | 128.50 | - | 147.21 | 70.37 | 4.23 | - | 11.72 |
Sotac Pharmaceuticals Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Sotac Pharmaceuticals is currently unavailable
Please check back later.
Shareholding Insights
Promoter(s) holds a high stake in the company at 72.85%- FIIs are invested in this company
- FIIs holding has increased by 6.24 percentage points from previous quarter
Mutual Funds are not invested in this company.
Sotac Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-28 | Audited Results, Dividend & Others |
| 2024-10-29 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| 2024-05-17 | Audited Results & Others |
| 2023-11-06 | Quarterly Results |
About the company Sotac Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE0O2D01012
- BSE Code
- NSE CodeSOTAC
Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Company's services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeutic portfolio including anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal and cephalosporin. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its products are supplied across 14 states in India, and it exports its products to over 20 countries worldwide. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Lifesciences Private Limited and Sotac Research Private Limited.
Sotac Pharmaceuticals Share Price FAQs
Sotac Pharmaceuticals is trading at 129.85 as on Tue Jul 08 2025 03:37:41. This is -% upper as compared to its previous closing price of 129.85.
The market capitalization of Sotac Pharmaceuticals is 143.48 Cr as on Tue Jul 08 2025 03:37:41.
The 52 wk high for Sotac Pharmaceuticals is 202.80 whereas the 52 wk low is 88.05
Sotac Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: -
- Sector P/E: 22.97
- Dividend Yield: -%
- D/E ratio: -
Sotac Pharmaceuticals reported a net profit of 8.03 Cr in 2025.
Quick Links